Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Explore this paper's citation graph
Summary
Pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, respectively.
- Type
- article
- Published
- 2014-06-01
- Cited by
- 6,333
- References
- 29
- Access
- Open access
- OpenAlex
- https://openalex.org/W1968812902
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:2479838
Keywords
Medicine, Cancer, Incidence (geometry), Thyroid cancer, Colorectal cancer
References
- Advances in the surgical management of pancreatic cancer.
- Deconstructing the Drug Development Process: The New Face of Innovation
- Translational Research Working Group Developmental Pathway for Biospecimen-Based Assessment Modalities
- The effect of fecal occult-blood screening on the incidence of colorectal cancer.
- Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force
- Annual Report to the Nation on the Status of Cancer, 1975–2006, Featuring Colorectal Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates
- Pancreatic cancer death rates by race among US men and women, 1970-2009.
- Primary liver cancer: worldwide incidence and trends.
- Annual Report to the Nation on the Status of Cancer, 1975-2010, Featuring Prevalence of Comorbidity and Impact on Survival among Persons with Lung, Colorectal, Breast or Prostate Cancer
- Current thyroid cancer trends in the United States.
- Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives
- Do all cancers need to be treated? The role of thyroglobulin in the management of thyroid cancer: the 2006 Hayes Martin lecture.
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
- Future of cancer incidence in the United States: burdens upon an aging, changing nation.
- Management of hepatocellular carcinoma: An update
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- Overdiagnosis in cancer.
- Cancer statistics, 2014
- Cancer statistics
- Cáncer
Cited by
- Thyroid Cancer and Tumor Collaborative Registry (TCCR)
- Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
- Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers.
- Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
- Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer
- Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
- Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong?
- Evaluation of Neurotensin Receptor1 as a Potential Imaging Target in Pancreatic Ductal Adenocarcinoma
- Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
- Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
- Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.
- Nano-Pulse Stimulation Ablates Orthotopic Rat Hepatocellular Carcinoma and Induces Innate and Adaptive Memory Immune Mechanisms that Prevent Recurrence
- lncRNA H19 predicts poor prognosis in patients with melanoma and regulates cell growth, invasion, migration and epithelial–mesenchymal transition in melanoma cells
- Duktales Adenokarzinom des Pankreas
- Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer
- Epidemiology and risk factors of pancreatic cancer
- Coffee consumption and risk of pancreatic cancer: a systematic review and dose–response meta-analysis
- An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer
- Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
- Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance
Related papers
- Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer
- Novel combination of serum microRNA for detecting breast cancer in the early stage
- Causes of death in men with prostate cancer: an analysis of 50 000 men from the Thames Cancer Registry
- [Clinical features of multiple primary cancers including prostate cancer].
- Clinicopathologic characteristics of cancer of North Korean defectors
- An Analysis on Cancer Incidence of Elderly Patients in Yangcheng County of Shanxi Province,1998~2007
- Lung cancer screening CT: from a radiological point of view.